Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Roivant Sciences Ltd. (ROIV)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.7000+0.0500 (+1.37%)
At close: 04:00PM EDT
Advertisement
Sign in to post a message.
  • K
    Krysta
    Trading can only be profitable when you use an accurate signal and not signals you get online. I used a lot of copy trading software and none ever worked. I got introduced to Henry Artem's strategy early this year, and I can say I have made over $1.2m on trading. You can contact him via 🆃🅴🅻🅴🅶🆁🅼 (HENRYARTEM).
  • E
    Emil
    The stock market trading is like sailing a ship on a rough sea and if you ain't got an experienced captain at the deck, your ship is sure to crash!!! Likewise, trading, the importance of a mentor is never overlooked, cos no matter how good the strategy is, you might get confused at a point and that's where the expertise comes on and if not properly guided. It will result in a whole lot of losses. That's why it's pertinent to have a very good trader to guide you. Crypto still remains the Future of Finance, I will advise every investor to keep buying and trading, to increase your portfolio this month by working with Alex Moolman through his registered investment company. Just do something that will make you money while you sleep, no matter how little. The pandemic has been a perfect eye-opener for us all to really see how life can be without your usual income stream. You can reach him on * t**elegram *@tradewithhenryfx
  • A
    Angelo
    Was on the conference call. Super bullish. $ in bank. Launching immediately nice % of a 28 billion dollar psoriasis industry. Top line results. Long swing
    Bullish
  • S
    ShogunShiva
    $ROIV $ABUS Why isn't ROIVant suing PFE/BionTech. Interesting that Acuitas is suing ABUS. It's a proxy for PFE. Acuitas already lost once before and settled in 2018 over sub licensing. "settlement stipulates that the four non-exclusive viral vaccine sublicenses previously granted to Moderna are the only sublicenses to survive. These four sublicenses, previously granted by Acuitas to Moderna under the pre-April 15, 2010 Arbutus LNP patent families, are each limited to a specific viral target. Moderna has no other rights to Arbutus’ broad suite of LNP intellectual property."

    Acuitas licensed from ABUS and sub licensed to MRNA. Very likely MRNA ran with it and was successful. So they tried to invalidate ABUS's patents and failed. Genevant sublicensed to BionTech for their oncology programs. PFE and BionTech collaborated on their Covid Vax. In all of this BionTech is silent so far while PFE pre-emptively is using Acuitas to sue ABUS.
  • C
    Crash
    I love this with all the future Biotech CRSP,BEAM,BNTX,all will need LNP
    Bullish
  • C
    Crash
    50% in BNTX you can't beat this
  • Y
    Yahoo Finance Insights
    Roivant Sciences is down 8.84% to 3.30
  • C
    Crash
    Let's see if we get insiders buying
    Bullish
  • C
    Crash
    CFO has left MRNA bodes well
    Bullish
  • C
    Crash
    What people don't know our wagon is hitched to BNTX
  • Y
    Yahoo Finance Insights
    Roivant Sciences reached an all time low at 3.68
  • Y
    Yahoo Finance Insights
    Roivant Sciences reached an all time low at 3.69
  • C
    Crash
    Setting at $3.20 on cash lol
    Bullish
  • C
    Comet
    Why?
  • C
    Crash
    (LNP) is the future with CRSP we are in the cat bird seat
    Bullish
  • C
    Crash
    Bought it for another reason but will take the kicker
    Bullish
Advertisement
Advertisement